Company news

Rhythm Biosciences Limited news in 2021

Rhythm Biosciences Limited's news releases, calls and decks from 2021, newest first.

View company

RHY Platform Technology Targets Five Cancers

December 13, 2021

Board and Management Restructure

November 30, 2021

CE Mark Granted for ColoSTAT

November 29, 2021

Change of Director's Interest Notice x 4

November 25, 2021

Application for quotation of securities - RHY

November 12, 2021

RHY - Institutional Investor Presentation

November 9, 2021

ColoSTAT Test Kits Deliver Consistent, High Accuracy Results

October 20, 2021

Rhythm Receives $2.4m R&D Tax Incentive

October 4, 2021

Rhythm Completes Recruitment for Clinical Trial (Study 7)

September 21, 2021

TGA Accepts Initial Regulatory Documentation

September 14, 2021

Rhythm Completes Strongly Oversubscribed $4.3M Rights Issue

September 7, 2021

Initial TGA Regulatory Documentation Submitted

August 18, 2021

Non Renounceable pro rata offer - Completion of despatch

August 9, 2021

Rights Issue Investor Presentation

July 30, 2021

Non renouneable rights issue prospectus

July 29, 2021

Rhythm Establishes US Entity To Drive US Expansion Strategy

July 14, 2021

Rhythm to Present at MST Access Investor Conference

June 17, 2021

RHY adds Sonic Clinical Services to ColoSTAT Clinical Trial

June 15, 2021

FY22 Strategic Update

May 17, 2021

Rhythm Betters ColoSTAT Results

May 5, 2021

Rhythm Extends ColoSTAT Clinical Trial to Western Australia

April 12, 2021

Rhythm Retains ISO13485 Certification

March 30, 2021

Study 6 Successfully Concluded - Exceptional Results

March 15, 2021

Rhythm Expands ColoSTAT Clinical Trial To Tenth Site

February 10, 2021

Initial Manufacturing of ColoSTAT Test-Kits Complete

January 19, 2021

Rhythm Advances ColoSTAT Study 7

January 18, 2021

Decks in 2021